Skip to main content

Paul M. Lieberman

NIH Rank #4387
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1869983Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$2.6M
Full award amounts, FY2025
Award Records
7
Records listing this PI
Award-Linked Rank
#4,387
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Paul M. Lieberman. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Paul M. Lieberman as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA282411-03R01
    EBNA1 Inhibitor for Treatment of EBV-positive DLBCL
    $534.3K
    award amount
  • 5R01CA140652-15R01
    Role of TERRA in Telomere Maintenance and Telomere Stress Response
    $434.7K
    award amount
  • 5P01CA281867-03P01
    Transcription and Replication of Oncogenic Viruses in Hypoxia
    $421.6K
    award amount
  • 5R01CA117830-18R01
    Epigenomic Control of KSHV Latency
    $410.2K
    award amount
  • 5R01DE017336-17R01
    Epigenetic Regulation of Epstein-Barr Virus
    $364.6K
    award amount
  • 5P30CA010815-56P30
    Consolidated Basic Cancer Research Program
    $210.4K
    award amount
  • 5P01CA269043-03P01
    Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
    $210.1K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Paul M. Lieberman as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Wistar Institute
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4166
  6. 2024
    Entered Top 25% Nationally
    Ranked #4166
  7. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  8. 2025
    R01 Grant Holder
  9. 2025
    Program/Center Grant Leader
  10. 2026
    $5M Cumulative Funding